10X Genomics is a company building products for research institutions and pharmaceutical companies across the life sciences, including oncology, immunology, and neuroscience. The company develops DNA sequencing technology and focuses on accelerating genomic discovery. Its integrated solutions include instruments, consumables, and software for analyzing biological systems.
Type | Public | |
Founded | 2012 | |
HQ | Pleasanton, CA, US | Map |
Website | 10xgenomics.com | |
Employee Ratings | More | |
Overall Culture | C+ | More |
USD | |
---|---|
Revenue (Q3, 2021) | 125.3m |
Gross profit (Q3, 2021) | 100.8m |
Gross profit margin (Q3, 2021), % | 80.4% |
Net income (Q3, 2021) | (17.2m) |
EBIT (Q3, 2021) | (15.9m) |
Market capitalization (12-May-2022) | 4.6b |
Closing stock price (12-May-2022) | 40.9 |
Cash (30-Sept-2021) | 600.4m |
EV | 4.0b |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|
Revenue | 53.6m | 55.8m | 61.2m | 71.9m | 42.9m | 71.8m | 105.8m | 115.8m | 125.3m |
Cost of goods sold | 14.0m | 15.0m | 15.5m | 15.1m | 10.1m | 14.4m | 17.1m | 4.9m | 24.5m |
Gross profit | 39.6m | 40.8m | 45.7m | 56.8m | 32.9m | 57.4m | 88.8m | 110.9m | 100.8m |
Gross profit Margin, % | 74% | 73% | 75% | 79% | 77% | 80% | 84% | 96% | 80% |
USD | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q1, 2020 | Q2, 2020 | Q3, 2020 | Q1, 2021 | Q2, 2021 | Q3, 2021 |
---|---|---|---|---|---|---|---|---|---|
Net Income | (3.6m) | (14.5m) | (24.1m) | (21.1m) | (61.3m) | (127.2m) | (11.6m) | (22.6m) | (39.8m) |
Depreciation and Amortization | 1.0m | 2.2m | 4.2m | 3.2m | 6.5m | 10.1m | 4.8m | 9.6m | 15.3m |
Inventories | (2.6m) | (3.8m) | (4.7m) | (4.1m) | (6.5m) | (9.8m) | (8.6m) | (14.2m) | (21.3m) |
Accounts Payable | (1.3m) | (986.0k) | 2.7m | (653.0k) | (2.8m) | (3.3m) | 10.9m | 9.7m | 12.2m |
USD | FY, 2018 |
---|---|
Debt/Equity | -0.1 x |
Debt/Assets | 0.2 x |
Financial Leverage | -0.6 x |
P/E Ratio | (1.4) |
Company Name | Date | Deal Size |
---|---|---|
Tetramer Shop | February 25, 2021 | |
ReadCoor | October 05, 2020 | $350 m |
CARTANA | September 16, 2020 | $41.2 m |
Spatial Transcriptomics | December 10, 2018 | |
EPINOMICS | August 28, 2018 |
10X Genomics revenue breakdown by business segment: 13.4% from Instruments, 84.6% from Consumables and 2.0% from Other
10X Genomics revenue breakdown by geographic segment: 53.3% from North America, 14.0% from China, 24.5% from Europe, the Middle East and Africa and 8.2% from Asia Pacific
10X Genomics has 23.85k Twitter Followers. The number of followers has increased 1% month over month and increased 3.3% quarter over quarter
8k
Tweets
775
Following
23.8k
Followers
42
Tweets last 30 days
7.1
Avg. likes per Tweet
95.2%
Tweets with engagement
C+
69/100
C-
65/100
B
73/100
When was 10X Genomics founded?
10X Genomics was founded in 2012.
Who are 10X Genomics key executives?
10X Genomics's key executives are Serge Saxonov, Kim Popovits and Shehnaaz Suliman.
How many employees does 10X Genomics have?
10X Genomics has 1,148 employees.
What is 10X Genomics revenue?
Latest 10X Genomics annual revenue is $298.8 m.
What is 10X Genomics revenue per employee?
Latest 10X Genomics revenue per employee is $260.3 k.
Who are 10X Genomics competitors?
Competitors of 10X Genomics include Oxford Nanopore Technologies, AbCellera Biologics and Benchling.
Where is 10X Genomics headquarters?
10X Genomics headquarters is located at 6230 Stoneridge Mall Rd, Pleasanton.
Where are 10X Genomics offices?
10X Genomics has offices in Pleasanton, San Francisco, Shanghai, Leiden and in 1 other location.
How many offices does 10X Genomics have?
10X Genomics has 5 offices.
Receive alerts for 300+ data fields across thousands of companies